Use of the concomitant serum dosage of CA 125, CA 19-9 and interleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent studies have proposed the measurement of CA 19-9 and IL-6 as an alternative to CA 125 as markers for endometriosis. This study was performed in order to verify the clinical value of serum CA 125, CA 19-9 and IL-6 levels, either by themselves or combined, in the detection of the disease. METHODS: In a prospective cohort study, serum concentrations of CA 125, CA 19-9 and IL-6 were measured in a consecutive series of 80 women of reproductive age who underwent laparoscopy for benign gynaecological pathologies. RESULTS: Endometriosis was documented in 45 women (stage I-II in 14 cases and stage III-IV in 31 cases). Patients with endometriosis had significantly higher levels of CA 125 than controls [23.4 IU/ml (13.3-37.6) versus 11.4 IU/ml (9.1-18.5), P < 0.001)]. Conversely, women with and without the disease were shown to have similar levels of both IL-6 pg/ml [0.6 (undetectable-1.4) versus 1.0 pg/ml (0.4-1.9), P = 0.09] and CA 19-9 [9.8 IU/ml (4.5-20.8) versus 7.4 IU/ml (2.8-11.5), P = 0.11]. The area under the receiver operating characteristics curve resulted in a statistically significant difference from the null hypothesis only for CA 125 (P < 0.001). Sensitivity and specificity of CA 125 were 27 and 97% respectively and were higher than those related to CA 19-9 and IL-6. Concomitant use of the three dosages led to a sensitivity and a specificity of 42 and 71% respectively. CONCLUSIONS: The concomitant dosage of CA 125, CA 19-9 and IL-6 does not add significant information in respect to the CA 125 test alone in diagnosing either early or advanced stages of endometriosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revised American Society for Reproductive Medicine classification of endometriosis: 1996
American Society for Reproductive Medicine (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81391-x · Cited by 3,018
Van Snick, J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001345 · Cited by 1,890
Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial
Bedaiwy, M. A. (2002) · Human Reproduction · doi:10.1093/humrep/17.2.426 · Cited by 485
The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis
Mol, B. W. J., Bayram, N., Lijmer, J. G., Wiegerinck, M. A. H. M., Bongers, M. Y., van der Veen, F., & Bossuyt, P. M. M. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00355-0 · Cited by 355
Chen, F., Soong, Y., Lee, N., & Lo, S. K. (1998) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.1998.770615.x · Cited by 73
Cited by
Peripheral biomarkers of endometriosis: a systematic review
May, K. E., Conduit-Hulbert, S. A., Villar, J., Kirtley, S., Kennedy, S. H., & Becker, C. M. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq009 · Cited by 418
“Studies published since continue to demonstrate a correlation between raised CA125 levels and endometriosis (Abrao et al., 1999; Somigliana et al., 2004; Agic et al., 2008; Seeber et al., 2008), and some imply a correlation with stage of disease (Chen et al., 1998; Amaral et al., 2006; Martinez et…”
BackgroundInfluentialBlood biomarkers for the non-invasive diagnosis of endometriosis
Nisenblat, V., Bossuyt, P. M., Shaikh, R., Farquhar, C., Jordan, V., Scheffers, C. S., Mol, B. W. J., Johnson, N., & Hull, M. L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012179 · Cited by 376
Chandler, R. L., Damrauer, J. S., Raab, J. R., Schisler, J. C., Wilkerson, M. D., Didion, J. P., Starmer, J., Serber, D., Yee, D., Xiong, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7118 · Cited by 323
Anglesio, M. S., George, J., Kulbe, H., Friedlander, M., Rischin, D., Lemech, C., Power, J., Coward, J., Cowin, P. A., House, C. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3314 · Cited by 258
Is Endometriosis Associated with Systemic Subclinical Inflammation?
Agic, A., Xu, H., Finas, D., Banz, C., Diedrich, K., & Hornung, D. (2006) · Gynecologic and Obstetric Investigation · doi:10.1159/000093121 · Cited by 231
“Considering the discrepancies between the studies, it is not easy to predict a useful marker in the diagnosis or management of endometriosis. A combination of some of the above-reported markers might be helpful. Several reports examined the potential use of different marker combinations in the diagnosis of endometrios…”
BackgroundEvaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis
Vodolazkaia, A., El-Aalamat, Y., Popovic, D., Mihalyi, A., Bossuyt, X., Kyama, C. M., Fassbender, A., Bokor, A., Schols, D., Huskens, D., et al. (2012) · Human Reproduction · doi:10.1093/humrep/des234 · Cited by 189
Serum cytokines as biomarkers for nonsurgical prediction of endometriosis
Othman, E. E.-D. R., Hornung, D., Salem, H. T., Khalifa, E. A., El-Metwally, T. H., & Al-Hendy, A. (2008) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.05.001 · Cited by 181
Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers
Mihalyi, A., Gevaert, O., Kyama, C. M., Simsa, P., Pochet, N., De Smet, F., De Moor, B., Meuleman, C., Billen, J., Blanckaert, N., et al. (2010) · Human Reproduction · doi:10.1093/humrep/dep425 · Cited by 161
Fassbender, A., Vodolazkaia, A., Saunders, P., Lebovic, D., Waelkens, E., De Moor, B., & D'Hooghe, T. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.01.097 · Cited by 150
“The authors concluded that neither serum IL-6 nor CA19-9 was useful as a diagnostic marker for endometriosis either individually or in combination with CA-125 [59] .”
BackgroundCan chemokines be used as biomarkers for endometriosis? A systematic review
Borrelli, G. M., Abrao, M. S., & Mechsner, S. (2014) · Human Reproduction · doi:10.1093/humrep/det401 · Cited by 102
Agic, A., Djalali, S., Wolfler, M. M., Halis, G., Diedrich, K., & Hornung, D. (2008) · Reproductive Sciences · doi:10.1177/1933719108318598 · Cited by 88
Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis
Kokot, I., Piwowar, A., Jędryka, M., Sołkiewicz, K., & Kratz, E. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052295 · Cited by 76
“[35] proposed a cut-off point for serum IL-6 concentration as 3.”
BackgroundMethodBarbosa, C. P., Souza, Â. M. B. D., Bianco, B., Christofolini, D., Bach, F. A. M., & Lima, G. R. D. (2009) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802009000600004 · Cited by 58
Identification and validation of novel serum markers for early diagnosis of endometriosis
Gajbhiye, R., Sonawani, A., Khan, S., Suryawanshi, A., Kadam, S., Warty, N., Raut, V., & Khole, V. (2012) · Human Reproduction · doi:10.1093/humrep/der410 · Cited by 53
Selected cytokines and glycodelin A levels in serum and peritoneal fluid in girls with endometriosis
Drosdzol‐Cop, A., & Skrzypulec‐Plinta, V. (2012) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2012.01860.x · Cited by 52
“Comparable outcomes were documented by other authors.(16,22,24,25) Figure 1 Receiver–operator curves of peritoneal fluid (PF) tumor necrosis factor (TNF)-a for the prediction of endometriosis.”
ResultAtherosclerosis in women with endometriosis
Pretta, S., Remorgida, V., Abbamonte, L. H., Anserini, P., Ragni, N., Del Sette, M., Gandolfo, C., & Ferrero, S. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.04.015 · Cited by 44
“In addition increased serum levels of interleukin 6, interleukin 1, and tumour necrosis factor-alpha have been described in women with endometriosis by some authors [15,16] but not by others [17].”
BackgroundBallester, M., Oppenheimer, A., Mathieu d’Argent, E., Touboul, C., Antoine, J.-M., Nisolle, M., & Daraï, E. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.022 · Cited by 44
Mohamed, M. L., El Behery, M. M., & Mansour, S. A. E.-A. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2539-4 · Cited by 35
“Moreover, others have indicated that CA125 may be more accurate at diagnosing women with later stages of disease [29–31].”
BackgroundPerformance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis
Mabrouk, M., Elmakky, A., Caramelli, E., Farina, A., Mignemi, G., Venturoli, S., Villa, G., Guerrini, M., Manuzzi, L., Montanari, G., et al. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2122-4 · Cited by 30
Identification of anti-syntaxin 5 autoantibody as a novel serum marker of endometriosis
Nabeta, M., Abe, Y., Takaoka, Y., Kusanagi, Y., & Ito, M. (2011) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2011.04.012 · Cited by 26
“Therefore, this assay is inadequate for the routine clinical assessment of endometriosis (Somigliana et al., 2004).”
MethodCopeptin is associated with the severity of endometriosis
Tuten, A., Kucur, M., Imamoglu, M., Kaya, B., Acikgoz, A. S., Yilmaz, N., Ozturk, Z., & Oncul, M. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3163-2 · Cited by 23
Serum anti-PDIK1L autoantibody as a novel marker for endometriosis
Nabeta, M., Abe, Y., Haraguchi, R., Kito, K., Kusanagi, Y., & Ito, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.008 · Cited by 22
Othman, E. E.-D. R., Hornung, D., & Al-Hendy, A. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.7.741 · Cited by 18
Metadata
- Authors
- Somigliana, E.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06-03
- Volume
- 19
- Issue
- 8
- Pages
- 1871-1876
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2135721067
- Cited by
- 138
- References
- 5
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.